SCD and pancreatic neoplasm: The tumor inhibition effects of A939572 were also documented in xenograft tumors of LOVO colorectal cancer cells [197], GA16, and (SCD1-overexpressing) MKN45 gastric cancer cells [164,165], Panc02 pancreatic cancer cells [198], and FT-t ovarian cancer cells [171].